Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (311-320 of 1,016) with videos related to

Pageof 102
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trialRicardo A Cruciani, Jenny J Zhang, Judith Manola, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 22, 2008
Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.SDavid H Henry, Hema N Viswanathan, Eric P Elkin, et al.
Arthritis Care & Research|January 22, 2020
Conversion of Functional Assessment of Chronic Illness Therapy-Fatigue to Patient-Reported Outcomes Measurement Information System Fatigue Scores in Two Phase III Baricitinib Rheumatoid Arthritis TrialsClifton O Bingham, Susan J Bartlett, Carol Kannowski, et al.
Health and Quality of Life Outcomes|December 21, 2019
Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trialsSara Shaunfield, Sally Jensen, Allison P Fisher, et al.
Psycho-Oncology|April 6, 2026
Identifying Longitudinal Trajectories of Quality of Life and Associated Risk and Protective Factors Among Cancer PatientsJiwon Kim, Karen Llave, Maja Kuharic, et al.
Journal of Patient-Reported Outcomes|June 23, 2026
Assessing content validity of the functional assessment of cancer therapy-cutaneous T-cell lymphoma (FACT-CTCL): a qualitative studyCaroline Raymundo, Jenny Jung Sun Park, Mengyang Di, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 9, 2012
Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancerDavid Cella, Zeeshan Butt, Hedy Lee Kindler, et al.
Cancer Medicine|October 11, 2020
Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302)Laura B Oswald, Ju-Whei Lee, Athanassios Argiris, et al.
The Lancet. Oncology|May 4, 2020
The increasing value of eHealth in the delivery of patient-centred cancer careFrank J Penedo, Laura B Oswald, Joshua P Kronenfeld, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 5, 2005
Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrumentKathleen J Yost, Mark V Sorensen, Elizabeth A Hahn, et al.
Pageof 102

Showing results (311-320 of 1,016) with videos related to

Sort By:
Pageof 102
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trialRicardo A Cruciani, Jenny J Zhang, Judith Manola, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 22, 2008
Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.SDavid H Henry, Hema N Viswanathan, Eric P Elkin, et al.
Arthritis Care & Research|January 22, 2020
Conversion of Functional Assessment of Chronic Illness Therapy-Fatigue to Patient-Reported Outcomes Measurement Information System Fatigue Scores in Two Phase III Baricitinib Rheumatoid Arthritis TrialsClifton O Bingham, Susan J Bartlett, Carol Kannowski, et al.
Health and Quality of Life Outcomes|December 21, 2019
Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trialsSara Shaunfield, Sally Jensen, Allison P Fisher, et al.
Psycho-Oncology|April 6, 2026
Identifying Longitudinal Trajectories of Quality of Life and Associated Risk and Protective Factors Among Cancer PatientsJiwon Kim, Karen Llave, Maja Kuharic, et al.
Journal of Patient-Reported Outcomes|June 23, 2026
Assessing content validity of the functional assessment of cancer therapy-cutaneous T-cell lymphoma (FACT-CTCL): a qualitative studyCaroline Raymundo, Jenny Jung Sun Park, Mengyang Di, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 9, 2012
Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancerDavid Cella, Zeeshan Butt, Hedy Lee Kindler, et al.
Cancer Medicine|October 11, 2020
Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302)Laura B Oswald, Ju-Whei Lee, Athanassios Argiris, et al.
The Lancet. Oncology|May 4, 2020
The increasing value of eHealth in the delivery of patient-centred cancer careFrank J Penedo, Laura B Oswald, Joshua P Kronenfeld, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 5, 2005
Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrumentKathleen J Yost, Mark V Sorensen, Elizabeth A Hahn, et al.
Pageof 102